Article
The 1.15A crystal structure of the Staphylococcus aureus methionyl-aminopeptidase and complexes with triazole based inhibitors.
Morphochem AG, WRO-1055/338 Schwarzwaldallee 215, 4058 Basel, Switzerland.
Journal of Molecular Biology (impact factor:
4).
10/2003;
332(1):13-21.
Source: PubMed
-
Citations (0)
- Cited In (1)
-
Article: Serendipitous discovery of novel bacterial methionine aminopeptidase inhibitors.
[show abstract] [hide abstract]
ABSTRACT: In this article we describe the application of structural biology methods to the discovery of novel potent inhibitors of methionine aminopeptidases. These enzymes are employed by the cells to cleave the N-terminal methionine from nascent peptides and proteins. As this is one of the critical steps in protein maturation, it is very likely that inhibitors of these enzymes may prove useful as novel antibacterial agents. Involvement of crystallography at the very early stages of the inhibitor design process resulted in serendipitous discovery of a new inhibitor class, the pyrazole-diamines. Atomic-resolution structures of several inhibitors bound to the enzyme illuminate a new mode of inhibitor binding.Proteins Structure Function and Bioinformatics 03/2007; 66(3):538-46. · 3.39 Impact Factor
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed.
The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual
current impact factor.
Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence
agreement may be applicable.
Keywords
1.15A crystal structure
active site
antimicrobial agents
inhibitors
inhibitors bind
MetAP structures
MetAP-Is
Methionyl aminopeptidases
N-terminal methionine residue
N2 atoms
novel class
potent non-peptidic inhibitors
prokaryotes
responsible
Staphylococcus aureus MetAP-I
subclasses
triazole moiety complexing
type II MetAPs
unique class
various 1,2,4-triazole-based derivatives